Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VION Biosciences is an active life science platform company focused on providing high-quality specialty chemicals, custom formulations, reagents, assays, buffers/lipids for drug development and diagnostics. It supports the entire lifecycle from discovery through commercialization by supplying mission-critical materials to biopharma/diagnostics/academic customers. Recent acquisitions include Aldon Corporation and Echelon Biosciences—expanding its capabilities in lipid nanoparticles crucial for mRNA/gene therapies. The company does not develop its own therapeutics but enables innovation in drug discovery/development with integrated manufacturing solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VION Biosciences.